Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial
帕博利珠单抗联合多西他赛对比单药多西他赛治疗既往接受过治疗的转移性去势抵抗性前列腺癌:随机、双盲、III期KEYNOTE-921试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-01283
Petrylak, Daniel P; Ratta, Raffaele; Matsubara, Nobuaki; Korbenfeld, Ernesto; Gafanov, Rustem; Mourey, Loic; Todenhöfer, Tilman; Gurney, Howard; Kramer, Gero; Bergman, Andries M; Zalewski, Pawel; De Santis, Maria; Armstrong, Andrew J; Gerritsen, Winald; Pachynski, Russell; Byun, Seok Soo; Retz, Margitta; Levesque, Eric; McDermott, Ray; Bracarda, Sergio; Manneh, Ray; Levartovsky, Meital; Li, Xin Tong; Schloss, Charles; Poehlein, Christian H; Fizazi, Karim